Core Viewpoint - Zhejiang Dongfang announced the establishment of the "Zheyao Dongfang (Kaihua) Life Health Science and Technology Fund" with a planned scale of 100 million yuan [1] Group 1: Fund Management and Participants - Zhejiang Dongfang's wholly-owned subsidiary, Zhejiang Dongfang Group Investment Co., Ltd., will act as the fund manager [1] - The fund is initiated in collaboration with Zhejiang Provincial Pharmaceutical Health Industry Group Co., Ltd. and Kaihua Huakong Investment Co., Ltd. [1] Group 2: Fund Contributions - The fund contributions include 1 million yuan each from Chanyin Chantu (Hangzhou) Equity Investment Co., Ltd. and Hanting Capital [1] - Zhejiang Dongfang and Zheyao Group will each contribute 19 million yuan [1] - Huakong Investment will contribute 60 million yuan [1]

Group 1 - Beijing Baoshichengyuan Equity Investment Partnership (Limited Partnership) was established with a total investment of 13 billion yuan (approximately 1.3 billion USD) [2][3] - The partnership was formed by major insurance asset management companies, including PICC Capital, Sino-Italian Asset Management, and Zhongcheng Capital [2][3] - The managing partner is Zhongcheng Capital Management (Beijing) Co., Ltd., with Sun Zhaolun as the designated representative [2][3] Group 2 - PICC Capital, a wholly-owned subsidiary of China Pacific Insurance Group, contributed 10 billion yuan, holding a 76.92% stake in the partnership [3][6] - Sino-Italian Asset Management contributed 3 billion yuan, representing a 23.08% stake [3][8] - Zhongcheng Capital contributed 1 million yuan, accounting for 0.0077% of the partnership [3][4] Group 3 - The partnership's business scope includes private equity investment, investment management, and asset management, subject to registration with the Asset Management Association of China [2][3] - The partnership is registered to operate from May 9, 2025, to May 8, 2045 [3][4] - Zhongcheng Capital, established in November 2012, manages assets in the range of 2 billion to 5 billion yuan [8][9]